Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142

被引:31
作者
Yang, Guangling [1 ]
Song, Ruipeng [1 ]
Wang, Limin [1 ]
Wu, Xuejian [1 ]
机构
[1] Zhengzhou Univ, Dept Orthoped, Affiliated Hosp 1, East 1 Jianshe Rd, Zhengzhou 450052, Henan, Peoples R China
关键词
Osteosarcoma; TP73-AS1; miR-142; Rac1; EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCELLULAR-CARCINOMA; HUMAN CANCERS; LUNG-CANCER; RAC1; METASTASIS; APOPTOSIS; LNCRNA; OVEREXPRESSION; EXPRESSION;
D O I
10.1016/j.biopha.2018.04.146
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Long non-coding RNA P73 antisense RNA 1 T (lncRNA TP73-AS1) has been shown to involve in the progression of numerous tumors. Nevertheless, the expression as well as the functional mechanisms of TP73-AS1 in osteosarcoma (OS) are still largely unknown. This study aimed to explore the roles and underlying mechanism of TP73-AS1 in OS progression. In thye present study, TP73-AS1 expression was significantly increased in OS tissues and cell lines. High TP73-AS1 expression was associated with poor overall survival of OS patients. TP73-AS1 knockdown suppressed OS cells proliferation and invasion in vitro as well as tumor growth in vivo. Furthermore, we identified that miR-142 could act as a direct target for TP73-AS1 and miR-142 inhibition reversed the suppression of OS cells proliferation and invasion induced by TP73-AS1 knockdown. In addition, we showed that TP73-AS1 could function as a sponge of miR-142 to positively regulate Rac1 in OS cells. Thus, our data suggested that TP73-AS1 served as an oncogenic lncRNA in OS progression, and could be regarded as an efficient therapeutic target in the treatment of OS.
引用
收藏
页码:1238 / 1245
页数:8
相关论文
共 38 条
[1]  
Ando Kosei, 2013, Cancers (Basel), V5, P591, DOI 10.3390/cancers5020591
[2]  
[Anonymous], J CELL BIOCH
[3]  
[Anonymous], J CELL BIOCH
[4]   RAC1: An Emerging Therapeutic Option for Targeting Cancer Angiogenesis and Metastasis [J].
Bid, Hemant K. ;
Roberts, Ryan D. ;
Manchanda, Parmeet K. ;
Houghton, Peter J. .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (10) :1925-1934
[5]   RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition [J].
Bousquet, E. ;
Calvayrac, O. ;
Mazieres, J. ;
Lajoie-Mazenc, I. ;
Boubekeur, N. ;
Favre, G. ;
Pradines, A. .
ONCOGENE, 2016, 35 (14) :1760-1769
[6]   LncRNA HOTAIR acts as competing endogenous RNA to control the expression of Notch3 via sponging miR-613 in pancreatic cancer [J].
Cai, Huihua ;
Yao, Jie ;
An, Yong ;
Chen, Xuemin ;
Chen, Weibo ;
Wu, Di ;
Luo, Boyang ;
Yang, Yong ;
Jiang, Yong ;
Sun, Donglin ;
He, Xiaozhou .
ONCOTARGET, 2017, 8 (20) :32905-32917
[7]  
Chen Q., 2017, AXIS CELL DEATH DIS, V8, pe2906
[8]   Long non-coding RNAs: new players in cell differentiation and development [J].
Fatica, Alessandro ;
Bozzoni, Irene .
NATURE REVIEWS GENETICS, 2014, 15 (01) :7-21
[9]   RASAL2 activates RAC1 to promote triple-negative breast cancer progression [J].
Feng, Min F ;
Bao, Yi ;
Li, Zhimei ;
Li, Juntao ;
Gong, Min ;
Lam, Stella ;
Wang, Jinhua ;
Marzese, Diego M. ;
Donovan, Nicholas ;
Tan, Ern Yu ;
Hoon, Dave S. B. ;
Yu, Qiang .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (12) :5291-5304
[10]  
Geller David S, 2010, Clin Adv Hematol Oncol, V8, P705